Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l-Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β-l-Ribofuranosyl-1H-Benzimidazole

• Published in: Journal of Virology Vol. 73; no. 9; pp. 7271 - 7277
• Main Authors: Zacny, V L, Gershburg, E, Davis, M G, Biron, K K, Pagano, J S
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.09.1999
• Subjects: Acyclovir - pharmacology; Antigens, Viral - genetics; Antigens, Viral - metabolism; Antiviral Agents - pharmacology; Benzimidazoles - pharmacology; Cell Line; Dichlororibofuranosylbenzimidazole - chemistry; Dichlororibofuranosylbenzimidazole - pharmacology; Epstein-Barr virus; Herpesvirus 4, Human - drug effects; Herpesvirus 4, Human - physiology; Human cytomegalovirus; Humans; Phosphorylation - drug effects; Ribonucleosides - pharmacology; Transcription, Genetic - drug effects; Vaccines and Antiviral Agents; Virus Replication - drug effects
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.73.9.7271-7277.1999

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI